glp 1 als Frontiers Can GLP-1 Medications Help MCAS,

Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

Changes in quality of life and liver function were assessed at 6 months

GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper ion, found in human blood plasma

Most clients see noticeable results after 6-8 sessions, with optimal results achieved after 6-8 sessions

Therefore, a protein-based formulation with no/low toxicity risks should be implemented in the transporters

This increases the peptides half-life and hence its activity